ArticleBritish journal of cancer2017

Camptothecin suppresses NRF2-ARE activity and sensitises hepatocellular carcinoma cells to anticancer drugs.

Feng Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.